510(k) Report

510(k) · Cleared

Cleared

TriSalus Infusion System

K193107510(k) TraditionalCleared Dec 3, 201925-day reviewClass II21 CFR 870.1210

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Trisalus Life Sciences · KRA Catheter, Continuous Flush

Cleared on Dec 3, 2019 as substantially equivalent to K171355 (Surefire Medical, Inc., 2017) after a 25-day review. Its family tree reaches back 7 generations to 2001.

Decided
Dec 3, 2019
Review
25 days
Class
Class II
Product code
KRA
Recalls
None
Predicates
1

Its longest line of descent runs back 7 generations to K003105 (2001). 9 ancestors in all, the oldest K915414 (1992). No later device cites it as a predicate yet.

  1. Root · 7 generations backK003105 Biosphere Medical Infusion CatheterBiosphere Medical · 2001
  2. 6 generations backK062126 Embocath Plus Infusion Microcatheter, Model Ecp-100 and Ecp-135Biosphere Medical, Inc. · 2006
  3. 5 generations backK110459 Surefire Infusion Catheter SystemSurefire Medical, Inc. · 2011
  4. 4 generations backK121677 Surefire HI-Flow MicrocatheterSurefire Medical, Inc. · 2012
  5. 3 generations backK143588 Surefire Infusion System 021Surefire Medical, Inc. · 2015
  6. 2 generations backK160662 Surefire Infusion SystemSurefire Medical, Inc. · 2016
  7. 1 generation backK171355 Surefire Precision Infusion SystemSurefire Medical, Inc. · 2017
  8. This deviceK193107 TriSalus Infusion SystemTrisalus Life Sciences · 2019
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K003105Biosphere Medical Infusion CatheterBiosphere Medical2001—
−6K062126Embocath Plus Infusion Microcatheter, Model Ecp-100 and Ecp-135Biosphere Medical, Inc.2006—
−5K110459Surefire Infusion Catheter SystemSurefire Medical, Inc.2011—
−4K121677Surefire HI-Flow MicrocatheterSurefire Medical, Inc.2012—
−3K143588Surefire Infusion System 021Surefire Medical, Inc.2015—
−2K160662Surefire Infusion SystemSurefire Medical, Inc.2016—
−1K171355Surefire Precision Infusion SystemSurefire Medical, Inc.2017—
0 (this device)K193107TriSalus Infusion SystemTrisalus Life Sciences2019—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199210
200910
FIG. 1 — Lineage of K193107, 2001–2019Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KRA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KRA device

  1. #1 K253509 TriSalus TriNav Advance Infusion Systemscore 14.5 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K171355Surefire Precision Infusion System
Summary page 4
…ation: 21 CFR 870.1210 Primary Product Code: KRA Secondary Product Code: DQO Primary Predicate Device  Surefire Precision Infusion System K171355 (also marketed as Surefire Infusion System) Reference Predicate Devices  Surefire Infusion System 021…
Surefire Medical, Inc.2017—
†K121677Surefire HI-Flow MicrocatheterSurefire Medical, Inc.2012—
†K180677Surefire Spark Infusion SystemSurefire Medical, Inc.2018—

Also cleared against K171355: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 18 years and passes through 4 companies; a new generation was cleared every 2.5 years on median.
  • None of the 9 ancestors has a recall.
  • 1 other device also cites its predicate K171355.

How does its category compare?

All KRA devices

KRA Catheter, Continuous Flush: FDA decisions, review times, recalls and adverse event reports over 20 years. 2019, this device’s year, is highlighted.

FDA decisions per year · KRA

1in 2025

2007: 52008: 72009: 52010: 22011: 22012: 32013: 32014: 42016: 82017: 42018: 42019: 42020: 62021: 62022: 62023: 72025: 12026 (partial year): 5
2007high 8 (2016) · low 0 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KRA

63in 2023

2007: 44 days median2008: 144 days median2009: 69 days median2012: 29 days median2013: 126 days median2014: 61 days median2016: 122 days median2017: 166 days median2018: 178 days median2019: 133 days median2020: 29 days median2021: 108 days median2022: 228 days median2023: 63 days median2026 (partial year): 268 days median
2007high 268 (2026) · low 29 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KRA

41so far in 2026, the most since 2007

2007: 22008: 62009: 82010: 262011: 32012: 32013: 22014: 3, 2 Class I2015: 12016: 3, 1 Class I2019: 4, 4 Class I2020: 12023: 22026 (partial year): 41
2007high 41 (2026) · low 0 (2017)2026

Class I (7 since 2007) Class II/III not classified

Adverse event reports per year · KRA

980in 2025

2007: 1182008: 1172009: 1872010: 3552011: 2392012: 2172013: 2092014: 2762015: 3392016: 4182017: 5382018: 4342019: 4182020: 3812021: 4402022: 5432023: 8292024: 9422025: 980
2007high 980 (2025) · low 117 (2008)2025

MAUDE reports naming product code KRA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20075442118
200871446117
20095698187
20102—26355
20112—3239
20123293217
201331262209
20144613 (2)276
20150—1339
201681223 (1)418
201741660538
201841780434
201941334 (4)418
20206291381
202161080440
202262280543
20237632829
20240—0942
20251—0980
2026526841—

What is it indicated for?

The TriSalus Infusion System is intended for use in angiographic procedures to deliver radiopaque media and therapeutic agents to selected sites in the peripheral vascular system.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K193107: TriSalus Infusion System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K193107

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026